Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Malignant Neoplasm
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Outcomes Assessor)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive the Quit2Heal app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it. ARM II: Patients receive the QuitGuide app a...
OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive the Quit2Heal app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it. ARM II: Patients receive the QuitGuide app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it. After randomization, patients are followed up at 3, 6, and 12 months.
Tracking Information
- NCT #
- NCT04409236
- Collaborators
- National Cancer Institute (NCI)
- American Cancer Society, Inc.
- Investigators
- Principal Investigator: Jonathan Bricker Fred Hutch/University of Washington Cancer Consortium
Get Well Soon